Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1999
03/31/1999EP0905252A2 Modular promoter construct
03/31/1999EP0905251A1 Expression of heterologous protein in yeast
03/31/1999EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA
03/31/1999EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it
03/31/1999EP0905247A2 MurF polynucleotides and polypeptides from Staphylococcus
03/31/1999EP0905246A1 Cloning of chicken anaemia DNA
03/31/1999EP0905245A1 Staphylococcal polypeptides Spo0J1
03/31/1999EP0905244A2 FolC from Streptococcus
03/31/1999EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue
03/31/1999EP0905242A1 Method for controlling water content of plant
03/31/1999EP0905241A1 Amino-terminally truncated c-c chemokines as chemokine antagonists
03/31/1999EP0905240A1 Amino-terminally truncated c-c chemokines as chemokine antagonists
03/31/1999EP0905239A2 Gene encoding Afadin-1
03/31/1999EP0905238A2 Pigrl-1, a member of immunoglobin gene superfamily
03/31/1999EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily
03/31/1999EP0905236A1 Transcription factor DP-1
03/31/1999EP0905235A2 Vascular smooth muscle cell growth factor
03/31/1999EP0905234A2 Allelic variant of human STAT3
03/31/1999EP0905233A2 Staphylococcus aureus trigger factor
03/31/1999EP0905143A2 Complex of human growth hormone and zinc and use
03/31/1999EP0905142A1 Inhibitors against prostate-specific antigen
03/31/1999EP0905141A1 Peptide fragment of the limulus anti-LPS factor (LALF) having antiviral action
03/31/1999EP0905140A1 Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use
03/31/1999EP0904785A1 Protein C inhibitor against hypercoagulation
03/31/1999EP0904541A1 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA)
03/31/1999EP0904539A1 Inhibiting protein interactions
03/31/1999EP0904405A2 Biomarkers for detection, diagnosis and prognosis of prostate cancer
03/31/1999EP0904402A1 Interaction trap systems for detecting protein interactions
03/31/1999EP0904398A1 Chemokine alpha 3
03/31/1999EP0904394A1 Chicken embryo lethal orphan (celo) virus
03/31/1999EP0904393A1 Parapoxvirus vectors
03/31/1999EP0904390A1 Recombinant plant genome, comprising specific chicory genes and a nucleotide sequence conferring male sterility, and its use.
03/31/1999EP0904388A1 MONITORING OF TRANSGENIC PLANTS WITH $i(IN VIVO) MARKERS
03/31/1999EP0904387A1 Nematode-inducible plant gene promoter
03/31/1999EP0904380A2 Synthetic hiv genes
03/31/1999EP0904379A2 Simian-human hav having a chimeric 2c protein
03/31/1999EP0904378A1 Hepatitis b monoclonal antibodies
03/31/1999EP0904377A2 Bacillus thuringiensis genes encoding nematode-active toxins
03/31/1999EP0904376A2 Proteins involved in the synthesis and assembly of o-antigen in pseudomonas aeruginosa
03/31/1999EP0904375A2 Antifungal polypeptide and methods for controlling plant pathogenic fungi
03/31/1999EP0904374A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
03/31/1999EP0904372A2 Human phospholipase inhibitor
03/31/1999EP0904371A2 Use of the green fluorescent protein as a screenable marker for plant transformation
03/31/1999EP0904370A1 Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
03/31/1999EP0904369A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
03/31/1999EP0904368A1 Al-2 neurotrophic factor
03/31/1999EP0904367A1 Scf analog compositions and methods
03/31/1999EP0904366A1 Apo-2li and apo-3 apoptosis polypeptides
03/31/1999EP0904365A1 Antigenically reactive regions of the hepatitis-a virus polyprotein
03/31/1999EP0904355A1 Method of activating denatured protein
03/31/1999EP0904353A1 Cell culture process and medium, cellular composition obtained and its application as production system and study model
03/31/1999EP0904352A1 Cell line
03/31/1999EP0904349A1 Transgenic non-human mammals with progressive neurologic disease
03/31/1999EP0904295A1 Process for separating and analyzing hydrophobic proteins using thin layer chromatography
03/31/1999EP0904294A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
03/31/1999EP0904293A1 An interleukin-5 antagonist
03/31/1999EP0904292A1 Growth differentiation factor-14
03/31/1999EP0904291A2 Antipathogenic peptides and compositions comprising them
03/31/1999EP0904290A2 Nucleic acid encoding gai gene of arabidopsis thaliana
03/31/1999EP0904289A1 Candida albicans tata-binding protein, nucleic acid and assays
03/31/1999EP0904288A2 Pathogenic escherichia coli associated protein
03/31/1999EP0904287A2 Cytokine designated lerk-8
03/31/1999EP0904285A1 Cyclic adhesion inhibitors
03/31/1999EP0904283A1 Human netrin-1
03/31/1999EP0904281A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
03/31/1999EP0904280A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
03/31/1999EP0904279A1 Novel tumor suppressor gene, dpc4
03/31/1999EP0904278A1 Apoptosis inducing molecule ii
03/31/1999EP0904277A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
03/31/1999EP0904276A1 A plant nuclear scaffold attachment region which increases gene expression
03/31/1999EP0904109A1 Targeting macromolecular prodrugs to t lymphocytes
03/31/1999EP0904105A1 Novel compounds
03/31/1999EP0904104A1 Novel compounds
03/31/1999EP0904102A1 Milk of transgenic animals containing human alpha 1-antitrypsin and use of human alpha 1-antitrypsin to treat bile acid related diseases
03/31/1999EP0904096A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation
03/31/1999EP0904095A1 Chimeric isoprenoid synthases and uses thereof
03/31/1999EP0904094A1 Treatment of bone disorders with adrenomedullin
03/31/1999EP0904093A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma
03/31/1999EP0903981A1 Design of novel highly efficient hiv based packaging systems for gene therapy
03/31/1999EP0762886A4 Icam-1/lfa-1 short-chain peptides and method of using same
03/31/1999EP0743861A4 Radiolabeled annexins
03/31/1999EP0730659A4 METHOD FOR GENERATING A SUBTRACTED cDNA LIBRARY AND USES OF THE GENERATED LIBRARY
03/31/1999EP0679259B1 Diagnosis of leishmaniasis
03/31/1999EP0612353B1 Detection method for c-raf-1 genes
03/31/1999EP0344302B1 Regeneration and transformation of cotton
03/31/1999CN1212707A Prion-free collagen and collagen-derived products and implants for multiple biomedical applications, method of making thereof
03/31/1999CN1042733C Use of jackfruit seed agglutinin affinity chromatographic column
03/30/1999US5889191 Dna sequences; chloramphenicol acetyltransferase
03/30/1999US5889190 Stability; capable of systemic infections; transcription;gene expression
03/30/1999US5889177 Melatonin 1A receptor gene regulatory regions and uses thereof
03/30/1999US5889176 Nucleic acid molecules encoding non-infectious, non-replicating, HIV retrovirus-like particles containing heterologous antigenic anchor sequences
03/30/1999US5889175 Nucleic acids encoding HIV-1 trans-dominant mutants and their use to abrogate HIV-1 viral replication
03/30/1999US5889174 Nucleotide sequences encoding pesticidal proteins
03/30/1999US5889173 DNA encoding multifunctional neurothrophic factors
03/30/1999US5889172 DNA sequences for immunologically active peptides of pertussis toxin
03/30/1999US5889170 Human integral membrane protein
03/30/1999US5889169 Cell cycle regulatory protein p16 gene
03/30/1999US5889168 Fusion glycoprotein from HCMV and HSV
03/30/1999US5889167 Synthetic glucagon binding proteins
03/30/1999US5889166 Recombinant neospora antigens and their uses
1 ... 2296 2297 2298 2299 2300 2301 2302 2303 2304 2305 2306 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 ... 2916